Navigation Links
Cognizant Selected by Lilly to Deliver Commercial Operations Solutions to Enhance Sales and Marketing Effectiveness, Business Performance
Date:1/20/2011

ers' needs—the path forward to delivering business results in our increasingly challenging environment."

"We are committed to helping Lilly USA transform its commercial operations, providing a broad portfolio of integrated services to ensure business agility, continuous improvement, and the most innovative approaches. At a time of enormous regulatory and economic pressures in the life sciences industry, our BPaaS approach will help Lilly reduce  risk, have the flexibility to rapidly scale up or down, and be highly responsive to market demands," said Nagaraja Srivatsan, Senior Vice President and Head of Life Sciences, North America, for Cognizant.

About Cognizant

Cognizant (Nasdaq: CTSH) is a leading provider of information technology, consulting, and business process outsourcing services. Cognizant's single-minded passion is to dedicate our global technology and innovation know-how, our industry expertise and worldwide resources to working together with clients to make their businesses stronger. With over 50 global delivery centers and more than 100,000 employees as of December 1, 2010, we combine a unique global delivery model infused with a distinct culture of customer satisfaction. A member of the NASDAQ-100 Index and S&P 500 Index, Cognizant is a Forbes Global 2000 company and a member of the Fortune 1000 and is ranked among the top information technology companies in BusinessWeek's Hot Growth and Top 50 Performers listings. Visit us online at www.cognizant.com or follow us on www.twitter.com/Cognizant.

Forward-Looking Statements

This press release includes statements which may constitute forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, the accura
'/>"/>

SOURCE Cognizant
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Zila Inc. Product Selected to Identify Pre-Cancer in Study of Leading Cancer Treatment Chemotherapeutic - ERBITUX
2. Advanced Life Sciences to Present Data on Selected Cethromycin Therapeutic Studies at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
3. GeoVax Labs, Inc. Selected by Georgia Bio as 2008 Deal of the Year Award Winner in Life Sciences Industry
4. Caliper Life Sciences Optical Imaging Technology Selected to Aid Tuberculosis Research Efforts by the Texas A&M Health Science Center
5. Cepheid GeneXpert(R) System and Xpert(TM) MRSA Selected for up to 11 Victoria, Australia Hospitals in Rollout of Start Clean Strategy
6. XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention
7. Texas Cardiac Arrhythmia Institute at St. Davids Medical Center Selected to Conduct Clinical Trial for Device to Treat Atrial Fibrillation
8. Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program
9. Jennerex Therapeutic Research Collaboration With Ottawa Hospital Research Institute Selected for $10 Million Grant From Ontario Institute for Cancer Research
10. Keryx Biopharmaceuticals Phase 2 Data of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Renal Cell Cancer Selected for Oral Presentation at the Eighth International Kidney Cancer Symposium
11. Sangamo BioSciences Announces Research Collaboration With UCLA in Human Stem Cells Selected to Receive Clinical Research Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... 21, 2013  Janssen R&D Ireland (Janssen) today ... global Phase 3 PROMISE study demonstrating that use ... to sustained virologic response 12 weeks after the ... treatment-experienced genotype 1 chronic hepatitis C adult patients ... liver fibrosis, when administered once daily with pegylated ...
(Date:5/21/2013)... , May 21, 2013 Reportlinker.com ... is available in its catalogue: ... Reimbursement Scenario for Medical Devices in the ...   Changing Regulatory and ... US Market   ...
(Date:5/21/2013)... Va. , May 21, 2013   ... 22,000 pharmacies nationwide, announces today the publication of ... America,s Post-Reform Health Care System. The white paper ... reducing costs, and seeks public engagement to avert ... Personalized Pharmacist Care refers to a range of ...
Breaking Medicine Technology:Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 2Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 3Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 4Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 5Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 6Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 7Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market 2Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market 3Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market 4RxAlly Releases White Paper on Necessity of Personalized Pharmacist Care 2RxAlly Releases White Paper on Necessity of Personalized Pharmacist Care 3
... Health Company (NASDAQ-CM: FHCO) today announced that its exclusive ... successful in a public tender to supply the Brazilian ... FC2 Female Condoms.  The contract is valid through March ... at the Ministry of Health,s discretion. O.B. ...
... (NYSE: VAR ) is highlighting its ProBeam™ ... the 2011 PTCOG meeting here from May 8th-14th . ... frontier in proton therapy and has the potential to improve ... conventional X-ray radiotherapy," says Moataz Karmalawy, head of Varian,s particle ...
Cached Medicine Technology:The Female Health Company's Brazilian Distributor, Semina, Awarded Contract For Up To 20 Million FC2 Female Condoms 2The Female Health Company's Brazilian Distributor, Semina, Awarded Contract For Up To 20 Million FC2 Female Condoms 3Varian Medical Systems Spotlights Fully Integrated Intensity Modulated Proton Therapy at PTCOG 2011 Meeting 2Varian Medical Systems Spotlights Fully Integrated Intensity Modulated Proton Therapy at PTCOG 2011 Meeting 3
(Date:5/21/2013)... Healthcare industry leaders, health information technology ... Me Up” Emerging Healthcare Technology Conference, June 10 at ... This new event is part of the 11th ... healthcare leaders being held June 10-12 at the Fluno ... , Funding for healthcare information technology (IT) grew dramatically ...
(Date:5/21/2013)... It’s nearly summer and millions of kids ... practice for summer or fall sports. In many cases ... can begin. , To help parents during this busy ... sports or camp physicals at just $29. As ... child’s medical history, perform a physical exam and complete required ...
(Date:5/21/2013)... Everspark Interactive, one of the city's leading ... over the past year – and announced another milestone ... marketing efforts for Kids II, a designer of innovative ... a local effort, specializing in search engine optimization (SEO) ... company's website. The company now offers a host of ...
(Date:5/21/2013)... NY (PRWEB) May 21, 2013 Tools4ever, ... solutions, has made its Self Service Reset Password Management ... SSRPM, employees can now use the service on mobile ... that end users can easily reset their Windows passwords ... set of questions correctly, the user may then reset ...
(Date:5/21/2013)... -- Racial disparities exist in the treatment of non-small ... according to a large new study. Although most ... their initial treatment, researchers found that blacks were less ... the early stages of the disease. Hispanics were more ... 2 disease than white patients. "In our study ...
Breaking Medicine News(10 mins):Health News:“Start Me Up" Healthcare Conference: Where Healthcare CIOs, Entrepreneurs and Investors Meet 2Health News:MedSpring Offers Camp and Sports Physicals For $29 2Health News:Everspark Named Interactive Marketing Company for Kids II 2Health News:Tools4ever’s password reset software ready for BYOD 2Health News:Racial Disparities Seen in U.S. Lung Cancer Treatment 2
... French . , Montreal, December 3rd, 2008 ... Dr. Robert Koenekoop from the Research Institute at the Montreal ... million from the Canadian Institutes of Health Research (CIHR) and ... fund an ambitious research project to develop innovative gene therapies ...
... instability in people with the blood disorder Fanconi anemia ... carcinomas linked to human papillomavirus (HPV), according to a ... . , Researchers led by Cincinnati Children,s Hospital Medical ... for the FA (Fanconi Anemia) gene complex triggers cellular ...
... Corporation (Nasdaq: HLTH ) announced today the final ... of its common stock at a price of $8.80 per share, ... 25, 2008. As previously announced, HLTH exercised its right to ... tender offer and has accepted for purchase 83,699,922 shares, including all ...
... Coalition for Pulmonary Fibrosis (CPF) today announced the launch of ... fighting pulmonary fibrosis (PF), a devastating and ultimately fatal disorder ... than 128,000 Americans. Prevalence and incidence of PF has ... 40,000 lives each year - the same number as breast ...
... in broccoli and cabbage works by lowering the activity ... according to a University of California, Berkeley, study appearing ... journal Proceedings of the National Academy of Sciences ... trials in humans because it was found to stop ...
... RICHMOND, Va., Dec. 3 Pernessa Seele,Founder/CEO of The Balm ... Kay and approximately 300 faith and community leaders at a,Civic ... recognizing,President George W. Bush and First Lady Laura Bush,s leadership ... It was in his first State of the ...
Cached Medicine News:Health News:CA$2.4 million toward gene therapy for human degenerative retinal diseases 2Health News:Genetic breakdown in Fanconi anemia may have link to HPV-associated cancer 2Health News:Genetic breakdown in Fanconi anemia may have link to HPV-associated cancer 3Health News:Genetic breakdown in Fanconi anemia may have link to HPV-associated cancer 4Health News:HLTH Corporation Announces Final Results of Its Tender Offer 2Health News:HLTH Corporation Announces Final Results of Its Tender Offer 3Health News:CPF Updates Patient Education Materials to Meet Growing Demand for Pulmonary Fibrosis Information 2Health News:CPF Updates Patient Education Materials to Meet Growing Demand for Pulmonary Fibrosis Information 3Health News:CPF Updates Patient Education Materials to Meet Growing Demand for Pulmonary Fibrosis Information 4Health News:Broccoli compound targets key enzyme in late-stage cancer 2Health News:Broccoli compound targets key enzyme in late-stage cancer 3Health News:The Balm In Gilead Joins Saddleback Church in Thanking President Bush for His Leadership on Addressing HIV and AIDS Around the World 2
Wire lid retractor may be clamped to surgical drape with suture or elastic band. Large pair....
Sharp. 4 mm wide. Hand-Held...
Rigid rake retractor, 3 blunt prongs....
Rees bayonet forceps, standard, 5-1/2", TC....
Medicine Products: